BRUKINSA

BEIGENE USA, INC.🇺🇸 United States

FDA Page

Effective Date: Sep 4, 2026
Approval ID: 3e08fe23-d70e-424c-bc51-1222e320f902
Products: 2 registered
Version: 25

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use BRUKINSA safely and effectively. See full prescribing information for BRUKINSA. BRUKINSA (zanubrutinib) capsules, for oral useBRUKINSA (zanubrutinib) tablets, for oral useInitial U.S. Approval: 2019

Quick Stats

Total Products2

Labelers3

Label Sections36

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.